Cleared Traditional

K210430 - Intravascular Extension Set

K210430 is an FDA 510(k) clearance for Intravascular Extension Set, manufactured by Baxter Healthcare Corporation. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 126-day FDA review.

K210430 · Baxter Healthcare Corporation · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2021
Decision
126d
Days
Class 2
Risk

K210430 is an FDA 510(k) clearance for the Intravascular Extension Set. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Baxter Healthcare Corporation (Round Lake, US). The FDA issued a Cleared decision on June 18, 2021 after a review of 126 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Baxter Healthcare Corporation devices

FDA 510(k) Submission Details - K210430

510(k) Number K210430 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 12, 2021
Decision Date June 18, 2021
Days to Decision 126 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d faster than avg
Panel avg: 129d · This submission: 126d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 770
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K210430.
Insignis Subcutaneous Needle Sets
K202279 · Innovative Health Sciences, LLC · Aug 2021
Firefly Needleless Connector
K203796 · Puracath Medical, Inc. · Jul 2021
Medtronic Extended infusion set
K210544 · Unomedical A/S · Jul 2021
Needleless Connector
K210217 · Jiangsu Caina Medical Co.,Ltd · May 2021
Safety Subcutaneous Infusion Set
K201626 · Epic Medical Pte. , Ltd. · Mar 2021
Velano ExT Extension Set
K200439 · Velano Vascular · Feb 2021